Tuberculosis (TB) is the seventh most common cause of death globally (1). Mycobacterium tuberculosis, its causative agent, has achieved a spread in the human population unmatched by any other bacterial pathogen (2), despite the availability of effective short-course chemotherapy and the Bacille Calmette-Guerin vaccine. Important factors contributing to the high pathogenicity of M. tuberculosis are its highly impermeable cell wall, which prevents the uptake of most hydrophilic antibiotic drugs, and its high adaptability to environmental changes during the course of infection, including: nutrient deprivation, hypoxia, various exogenous stress conditions and the phagosomal environment (3). The complete genome sequence of M. tuberculosis H37Rv, the best-characterized strain of the bacterium, has identified several stress response genes which contribute to pathogenicity (4). Among these, the membrane protein Rv0899, encoded by the rv0899 gene, is thought to confer adaptation of M. tuberculosis to the acidic environment of the phagosome (5). Sequence analysis of the mycobacterial genomes shows that the gene is restricted to pathogenic mycobacteria associated with TB (M. tuberculosis, M. bovis) and other TB-related diseases (M. marinum, M. ulcerans, M. kansaii) and, thus, is an attractive candidate for the development of anti-TB chemotherapeutic agents. Notably, two M. tuberculosis H37Rv genes (Rv0900 and Rv0901) adjacent to Rv0899 also encode putative membrane proteins, and are found exclusively in association with Rv0899 in the same pathogenic mycobacteria, suggesting that the three may constitute an operon dedicated to a common function. Amino acid sequence analysis reveals that the 326-residue Rv0899 contains three domains (Figure 1). The N-terminal domain (M; residues 1-72) includes a sequence of 20 hydrophobic amino acids (residues 28-50) that is required for membrane translocation but is not cleaved (6), thus constituting a membrane anchor. The central domain (B; residues 73-200) shares homology with the BON (Bacterial OsmY and Nodulation) superfamily (pfam04972), a conserved, putative lipid binding sequence that is found in some osmotic shock protection proteins, secretins, haemolysins, nodulation specificity proteins, and channels (7). Finally, the C-terminal domain (C; residues 201-326) has homology to the OmpA-C-like superfamily (pfam00691), a periplasmic peptidoglycan-binding domain that is found in several types of bacterial membrane proteins, including in the C-terminus of the outer membrane protein OmpA from E. coli. Owing to its homology with E. coli OmpA, the rv0899 gene was originally denoted as ompA in the published genome sequence of M. tuberculosis (4), and an outer membrane porin activity was proposed for its protein product, which was subsequently named OmpATb (8). Figure 1 Amino acid sequence (A), domain organization (B), and conserved domain homology (C) of M. tuberculosis Rv0899. The M domain contains 20 hydrophobic amino acids (residues 28-50) with transmembrane (TM) sequence similarity. The B domain contains a sequence ... Indeed, Rv0899 was isolated with the mycobacterial cell wall fraction (6, 9), and a pore-forming activity was measured in liposomes and in planar lipid bilayers for purified, recombinant Rv0899 produced in E. coli (6, 8, 10). The N-terminal hydrophobic sequence was found to be required for ion channel activity (6, 8) and proteolytic studies indicated that a trypsin-resistant polypeptide, spanning residues 73 to 326, was responsible for the pore-forming properties of Rv0899. Furthermore, a polypeptide spanning residues 73 to 220 was found to be sufficient for inducing the channel characteristics of the native protein in lipid bilayers, when it was expressed as a fusion with the E. coli OmpA signal sequence to direct it to its presumed outer membrane location (10). Transport experiments further led to the hypothesis that Rv0899 could function as a porin (5). The rv0899 gene was also shown to be significantly up-regulated in wild-type M. tuberculosis bacteria exposed to acidic conditions, whereas a mutant, lacking rv0899, displayed a substantially impaired ability to grow at acidic pH in macrophages and in mice (5), suggesting that rv0899 could facilitate the growth of M. tuberculosis in a mammalian host by helping it overcome host defense mechanisms. Indeed, pH adaptation is a common trait of pathogenic bacteria (11) and it has been shown that mycobacteria, including M. tuberculosis, maintain a neutral internal pH in an acidic environment (12-16). However, the mechanisms utilized by M. tuberculosis to adapt to acidic environments are poorly understood. The proposed porin activity and the pH adaption activity of Rv0899 seem to be at odds with each other, since a general response by Gram-negative bacteria to acid stress is to reduce porin expression (17-19). To gain further insights to the function of Rv0899 we have characterized the structure and dynamics of residues 73 to 326, spanning the B and C domains, and have determined the three-dimensional structure of the central B domain, including the BON homology sequence. Rv0899 does not form a transmembrane β-barrel. Residues 73 to 326 form a globular structure, which encompasses two independently folded modules, corresponding to the B and C domains connected by a flexible linker. Both domains adopt mixed α/β secondary structures. The B domain adopts a fold that had not been previously documented in the Protein Data Bank (PDB), with three parallel/antiparallel α-helices on one face of the protein, packed against six parallel/antiparallel β-strands which form a β-sheet on the opposite face. The structure reveals the fold of a BON homology domain for the first time. The C domain adopts the typical α/β structure of peptidoglycan-binding domains in the OmpA-C-like superfamily. The overall architecture of the protein and the unexpected structure of the B domain make it difficult to reconcile a porin activity with its central domain, but suggest alternative modes of membrane association. Throughout this article, we refer to the protein as Rv0899, rather than OmpATb, because its homology to E. coli OmpA is limited to the C domain, and because our studies show that it is not a β-barrel.